Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Daiichi Sankyo
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
36
72
108
144
180
216
252
288
324
360
Prolia
(denosumab) / Amgen
TheraCIM
(nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
Zelboraf
(vemurafenib) / Roche
Savaysa
(edoxaban) / Daiichi Sankyo
Invokana
(canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe
Enhertu
(fam-trastuzumab deruxtecan-nxki) / Daiichi Sankyo, AstraZeneca
FluMist Quadrivalent
(live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Injectafer
(ferric carboxymaltose) / Zeria Pharma, Daiichi Sankyo
Venofer
(iron sucrose complex) / Daiichi Sankyo, CSL Behring
Kuvan
(sapropterin) / BioMarin, Daiichi Sankyo
Benicar
(olmesartan medoxomil) / Daiichi Sankyo
Emgality
(galcanezumab-gnlm) / Eli Lilly, Daiichi Sankyo, Organon
Turalio
(pexidartinib) / Daiichi Sankyo
Tenelia
(teneligliptin) / Daiichi Sankyo, Mitsubishi Tanabe
AndexXa (coagulation factor Xa
(recombinant), inactivated -zhzo) / Daiichi Sankyo, AstraZeneca
Amjevita
(adalimumab-atto) / Amgen, Daiichi Sankyo
Nexlizet
(bempedoic acid/ezetimibe) / Esperion Therap, Otsuka, Daiichi Sankyo
Gracevit
(sitafloxacin) / Daiichi Sankyo
